LBF20207PG56: Difference between revisions

(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1746 |LipidMaps=LMFA03010064 |SysName= 9-Oxo- (11alpha,15S) -dihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-o...)
 
No edit summary
 
Line 6: Line 6:
|LipidBank=XPR1746
|LipidBank=XPR1746
|LipidMaps=LMFA03010064
|LipidMaps=LMFA03010064
|SysName= 9-Oxo- (11alpha,15S) -dihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-oic acid
|SysName=9-Oxo- (11alpha,15S) -dihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid
|Common Name=&&15S-15-methyl Prostaglandin E_2&&9-Oxo- (11alpha,15S) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&&
|Common Name=&&15S-15-methyl Prostaglandin E_2&&9-Oxo- (11alpha,15S) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&&
|Source=
|Source=

Latest revision as of 08:41, 21 October 2010

LipidBank Top
(トップ)
Fatty acid
(脂肪酸)
Glycerolipid
(グリセロ脂質)
Sphingolipid
(スフィンゴ脂質)
Journals
(雑誌一覧)
How to edit
(ページの書き方)


Upper classes: LB LBF



15S-15-methyl Prostaglandin E2
LBF20207PG56.png
Structural Information
9-Oxo- (11α,15S) -dihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid
  • 15S-15-methyl Prostaglandin E2
  • 9-Oxo- (11α,15S) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid
Formula C21H34O5
Exact Mass 366.240624198
Average Mass 366.49166
SMILES C(=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)[C@](C)(O)CCCCC
Physicochemical Information
15(S)-15-methyl Prostaglandin E2 inhibits gastric acid secretion and consequent ulcer formation. Kimball_FA et al.
Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms
Reported Metabolites, References
Biospecies ID Compound Name Reference Comment
n.a. LBF20207PG56 See above. Kimball_FA et al. 1975